Page last updated: 2024-08-24

halofuginone and Pulmonary Hypertension

halofuginone has been researched along with Pulmonary Hypertension in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Babicheva, A; Balistrieri, F; Carr, SG; Chen, J; Izadi, A; Jain, PP; Lai, N; Makino, A; Rahimi, S; Rodriguez, M; Shyy, JY; Simonson, T; Song, S; Thistlethwaite, PA; Valdez-Jasso, D; Wang, J; Xiong, M; Yuan, JX; Zhao, T; Zheng, Q1

Other Studies

1 other study(ies) available for halofuginone and Pulmonary Hypertension

ArticleYear
Halofuginone, a promising drug for treatment of pulmonary hypertension.
    British journal of pharmacology, 2021, Volume: 178, Issue:17

    Topics: Animals; Calcium; Hypertension, Pulmonary; Hypoxia; Mice; Myocytes, Smooth Muscle; Pharmaceutical Preparations; Phosphatidylinositol 3-Kinases; Piperidines; Pulmonary Artery; Quinazolinones

2021